Rescue of Suprasellar Metastasis of EGFR-mutant NSCLC by Daily Osimertinib Re-escalation With Filgrastim Support.
- DOI
- 10.21873/invivo.14404
- Published
- 2026 Jul-Aug
- Container
- In vivo (Athens, Greece)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21873/invivo.14404,
title = {Rescue of Suprasellar Metastasis of EGFR-mutant NSCLC by Daily Osimertinib Re-escalation With Filgrastim Support.},
author = {Saito S and Matsuda S and Nakamura M and Takahashi R and Yamamoto R and Ibe M and Takamori M and Kitazono M},
year = {2026},
journal = {In vivo (Athens, Greece)},
doi = {10.21873/invivo.14404},
url = {https://doi.org/10.21873/invivo.14404}
}RIS
TY - JOUR TI - Rescue of Suprasellar Metastasis of EGFR-mutant NSCLC by Daily Osimertinib Re-escalation With Filgrastim Support. AU - Saito S AU - Matsuda S AU - Nakamura M AU - Takahashi R AU - Yamamoto R AU - Ibe M AU - Takamori M AU - Kitazono M PY - 2026 JO - In vivo (Athens, Greece) DO - 10.21873/invivo.14404 UR - https://doi.org/10.21873/invivo.14404 ER -
APA
S, S., S, M., M, N., R, T., R, Y., M, I., M, T., & M, K. (2026). Rescue of Suprasellar Metastasis of EGFR-mutant NSCLC by Daily Osimertinib Re-escalation With Filgrastim Support.. In vivo (Athens, Greece). https://doi.org/10.21873/invivo.14404
Source records
- pubmed · retrieved 2026-09-26T00:06:55.135Z